MULTIDISCIPLINARY ASSOCIATION for PSYCHEDELIC STUDIES
Research > Medical Marijuana
MAPS is currently seeking regulatory approval to conduct a study of smoked and/or vaporized marijuana for symptoms of PTSD in veterans of war.
MAPS is currently the only organization working to demonstrate the safety and efficacy of botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration.
MAPS’ efforts to initiate medical marijuana research have been hindered by the National Institute on Drug Abuse (NIDA) and the Drug Enforcement Administration (DEA) since its inception in 1986. NIDA’s monopoly on the supply of marijuana for research and the DEA’s refusal to allow researchers to grow their own has effectively paralyzed medical marijuana research, and for over ten years MAPS has been involved in legal struggles against the DEA to end this situation.
See below for frequently updated information about completed, ongoing, or planned MAPS studies, as well as details of our ongoing DEA lawsuit.
For media coverage of MAPS’ marijuana research and other projects, see MAPS in the Media.